Finding new ways to treat a type of brain cancer in children.
Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified Medulloblastoma
This study is looking at new ways to treat medulloblastoma, a type of brain tumor in kids, by using tiny particles to deliver special medicines that can help fight the tumor more effectively and with fewer side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10982488 on NIH RePORTER |
What this research studies
This research focuses on medulloblastoma, a common pediatric brain tumor, and aims to overcome treatment resistance. It investigates the use of specific inhibitors that target genetic pathways involved in tumor growth and survival. By developing nanoparticles to deliver these drugs more effectively across the blood-brain barrier, the study seeks to enhance the efficacy of treatment while minimizing side effects. Patients may benefit from a combination therapy that has shown promise in preliminary studies.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with medulloblastoma, particularly those who have shown resistance to current therapies.
Not a fit: Patients with other types of brain tumors or those who do not have medulloblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for children with medulloblastoma, improving survival rates and reducing side effects.
How similar studies have performed: Other research has shown success with similar approaches in targeting genetic pathways in cancer treatment, indicating potential for this study's methods.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Mahato, Ram I. — University of Nebraska Medical Center
- Study coordinator: Mahato, Ram I.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.